Skip to content
The teams behind Good Day BIO and Bio.News is live at the BIO CEO and Investor Conference in New York. The Marriott Marquis in […]
How to follow the BIO CEO and Investor Conference 2023 Read More »
Thanks for joining us in Year 1 of Bio.News. We published over 700 stories in less than one year – and these were the
Our Top 15 Most-Clicked Stories of 2022 Read More »
While midterms results are still being tallied, we know a few key election results—and these results can give us some early insight into the
What we know (so far) the day after the midterms Read More »
The midterms are here. And while the days of knowing key race results the evening of Election Day seem to be long gone, it’s
2022 Midterms Preview: 4 things to watch on Election Day Read More »
We know industry partnerships with patient advocacy organizations are essential to drug R&D—but the industry needs to think beyond traditional partnerships towards engaging with
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit in Washington, D.C.? It’s all about
What we learned on Day 1 of the Patient and Health Advocacy Summit Read More »
Washington, D.C., is all about who you know—and coalitions of people and groups with the same goals are key to getting stuff done. During
Patient advocacy coalitions can create change – here’s how Read More »
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit returns to an in-person format for the first time since before the COVID-19 pandemic—and
What to know about the BIO Patient and Health Advocacy Summit Read More »
Echoing a bipartisan Senate letter last week, two top House trade leaders are raising serious concerns about the proposed expansion of the World Trade Organization (WTO)
House leaders speak out on COVID IP waiver expansion Read More »
U.S. investment in sensitive, cutting-edge research abroad would be more tightly controlled under the proposed National Critical Capabilities Defense Act. The bipartisan legislation would
Bill would limit U.S. investment in foreign research Read More »
